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Abstract We present evidence that gastrin, binding to a G
protein-coupled receptor, activates the p38-mitogen-activated
protein kinase (MAPK) pathway. Blockage of protein kinase C
(PKC) by GF109203X, depletion of intracellular calcium by
thapsigargin or inhibition of Src family kinases by PP2
prevented p38-MAPK activation and the Src kinase activity
stimulated by gastrin. Inhibition of the PI 3-kinase by
wortmannin or LY294002 did not affect these responses. In
addition, the p38-MAPK inhibitor, SB203580, repressed gastrin-
induced [3H]thymidine incorporation, indicating a major role of
p38-MAPK in the growth-promoting effect of gastrin. Our
results demonstrate that gastrin-induced DNA synthesis requires
p38-MAPK activation through mechanisms that involve calcium
mobilization, PKC and Src family kinases. ß 2001 Published
by Elsevier Science B.V. on behalf of the Federation of Euro-
pean Biochemical Societies.
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1. Introduction
Gastrin, originally identi¢ed as a potent stimulant of gastric
acid secretion, has also been shown to be a growth factor for
normal and malignant gastrointestinal tissues. Its trophic
e¡ects, mediated through a G protein-coupled receptor
(GPCR), the CCKB receptor (also known as CCK-2), have
been observed on normal gastrointestinal mucosa [1] as well
as on colon, gastric and pancreatic cancer cell lines in vitro or
transplanted in vivo [2^4]. More recent studies on transgenic
mice overexpressing gastrin or de¢cient for this gene have
con¢rmed the role of this hormone in cell proliferation [5,6].
Mitogen-activated protein kinase (MAPK) pathways are im-
portant signal transduction cascades linking extracellular
stimuli to intracellular responses. Among the di¡erent
MAPK pathways described in the literature (extracellular sig-
nal-regulated kinase (ERK) pathway, stress-activated protein
kinase/Jun-N-terminal kinase (JNK) pathway and p38-MAPK
pathway), the ERK pathway has been clearly involved in the
proliferative e¡ects induced by receptor tyrosine kinases, cy-
tokine receptors as well as GPCRs. Several laboratories, in-
cluding ours, have reported the activation of the ERK path-
way by the CCKB receptor and the contribution of this
signaling cascade in growth-promoting e¡ects mediated by
this receptor [7^9].
The p38-MAPK was initially identi¢ed as a signaling path-
way mediating cellular stress induced by UV, proin£amma-
tory cytokines, heat and osmotic shocks [10]. More recent
studies have shown that p38-MAPK can also play a critical
role in the regulation of cell proliferation by growth factors,
such as ¢broblast growth factor and hepatocyte growth factor
[11,12] or cytokines such as granulocyte colony stimulated
factor, interleukin (IL)-2 or IL-7 [13,14]. p38-MAPK has
also been shown to be activated by GPCRs [15,16]. However,
the contribution of this signaling pathway in the proliferative
e¡ects mediated by GPCR remains largely unknown.
In particular, activation of the p38-MAPK pathway by gas-
trin and its role in the proliferative e¡ects mediated by the
CCKB receptor have never been studied. Here, we have ex-
amined if the human CCKB receptor expressed in Chinese
hamster ovary (CHO) cells would induce the p38-MAPK ac-
tivation and whether this e¡ect would be involved in the
growth factor action of gastrin. We have also analyzed the
transduction mechanisms that may link the CCKB receptor to
the p38-MAPK pathway. Gastrin-dependent activation of the
CCKB receptor has been shown to induce the rapid hydrolysis
of phosphatidylinositol-biphosphates by phospholipase C
(PLC) to generate inositol triphosphates and diacyl-glycerol
which respectively mobilizes intracellular calcium and stimu-
lates protein kinase C (PKC). We therefore analyzed the con-
tribution of these early signals, generated by activation of
PLC, to the activation of the p38-MAPK by gastrin.
Since we have previously reported that ERK activation by
gastrin is mediated by a signaling cascade including the phos-
phorylation of Shc proteins by Src-like tyrosine kinases [7], we
have also analyzed the possibility that Src family kinases
could serve as intermediates between the CCKB receptor
and the activation of the p38-MAPK pathway.
Here, we report the activation of p38-MAPK by gastrin
through a mechanism that involves PKC, calcium mobiliza-
tion and Src family kinases. Our data also demonstrate an
essential role for the p38-MAPK pathway in transducing the
proliferative activity of gastrin.
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2. Materials and methods
2.1. Cell line
CHO cells, stably transfected with an expression plasmid encoding
the human CCKB receptor (Bmax = 2.87 þ 0.1 pmol/106 cells), were
obtained from C. Escrieut (Toulouse, France).
2.2. Immunoprecipitations and Western blotting analysis
Cells were serum-starved for 18 h before peptide addition. After
stimulation, the cells were washed and the soluble fractions, contain-
ing identical amounts of proteins, were immunoprecipitated with the
indicated antibodies, as described previously [17]. Proteins from im-
munoprecipitates or whole cell lysates were separated by SDS^PAGE
and transferred to polyvinylidene di£uoride membranes. Membranes
were blotted with the indicated antibodies, as described previously
[17]. Proteins were visualized using 125I-protein A (p38-MAPK detec-
tion) or horseradish peroxidase-chemoluminescent reagent and perox-
ide (phospho-ERK detection). The autoradiograms were densitometri-
cally analyzed, and the data from at least three separate experiments
plotted as fold stimulation and presented as means þ S.E.M.
2.3. Kinase assays
For p38-MAPK or JNK assays, anti-p38-MAPK or anti-JNK1
immunoprecipitates were washed twice with lysis bu¡er containing
1% Triton X-100 and three times in bu¡er B (50 mM HEPES^150
mM NaCl^0.1% Triton^10% glycerol) and then incubated for 30 min
in bu¡er B containing 10 mM Mg acetate, 3 Wg GST-ATF2 (activat-
ing transcription factor-2) (1^96) or 2 Wg GST-c-Jun (1^79), 5 WM
ATP and 0.3 WCi [Q-32P]ATP. Reaction was stopped by addition of
Laemmli sample bu¡er and boiling. Samples were analyzed by SDS^
PAGE and the gels were autoradiographed.
C-Src kinase assays were performed as described previously [7]. The
autoradiograms were densitometrically analyzed, and the data from at
least three separate experiments plotted as fold stimulation and pre-
sented as means þ S.E.M.
2.4. [3H]Thymidine incorporation
DNA synthesis was analyzed by measurement of [3H]thymidine
incorporation as described previously [7]. The results are means
þ S.E.M. of four experiments performed in triplicate.
2.5. Materials
[3H]Thymidine (18 Ci/mmol) was obtained from Amersham Phar-
macia Biotech. [Q-32P]ATP (7000 Ci/mmol) was from ICN. Anti-JNK1
and anti-p38K-MAPK, GST-c-Jun and GST-ATF2 were from Santa
Cruz, anti-p60-Src antibodies from Oncogene Science, anti-phospho-
tyrosine from Transduction Laboratories, anti-phospho-ERK anti-
bodies from New England Biolabs.
3. Results and discussion
3.1. Gastrin stimulates the phosphorylation and the activity of
p38-MAPK
We ¢rst investigated whether gastrin could induce the tyro-
sine phosphorylation of p38K-MAPK in CHO cells stably
expressing the human CCKB receptor.
Cells were treated with 10 nM of gastrin for various times
and lysates were immunoprecipitated with anti-phosphotyro-
sine antibodies. Western Blot with a speci¢c p38K-MAPK
antibody (Fig. 1A) revealed an increased phosphorylation of
p38K-MAPK in response to gastrin maximal at 5 min
(8.8 þ 1.9-fold) that decreased at 10 min.
We then analyzed the e¡ect of gastrin on the kinase activity
of p38K-MAPK. The p38K-MAPK activity was measured by
phosphorylation of the exogenous substrate GST-ATF2, after
immunoprecipitation of the cell lysates with an anti-p38K-
MAPK antibody. Results in Fig. 1B indicate that gastrin
treatment resulted in activation of the kinase with a time
course correlated to that observed for the phosphorylation
of the enzyme. The maximal stimulation, 5.3 þ 0.8-fold, ob-
served at 5 min, decreased at 10 min. Fig. 1C shows a late
kinetic of p38K-MAPK phosphorylation by gastrin. After 15
min of gastrin treatment, a stimulation of 2-fold over basal is
observed, that increased to 3-fold at 30 min. This phosphor-
ylation remained elevated for at least 2 h.
3.2. Role of PKC and calcium in the activation of p38-MAPK
by gastrin
Since the CCKB receptor is known to be linked to the PLC/
Fig. 1. Gastrin stimulates the phosphorylation and the activity of
p38-MAPK. Cells were stimulated for the times indicated with 10
nM of gastrin. Proteins from cell lysates were prepared and immu-
noprecipitated (IP) with anti-phosphotyrosine (P-Tyr) or anti-p38K-
MAPK antibodies then subjected to immunoblotting (IB) (A,C) or
p38K-MAPK assay (B) as described under Section 2. Comparable
amounts of proteins were detected in whole cell lysates or immuno-
precipitates of all the above experiments (data not shown).
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PKC pathway, we investigated whether PKC and calcium
mobilization contribute to gastrin-induced p38-MAPK activa-
tion.
In Fig. 2A,B, direct activation of phorbol ester-sensitive
PKC isoforms by 100 nM of phorbol 12-myristate 13-acetate
(PMA) for 20 min induced an increase in the phosphorylation
and activity of p38K-MAPK. However, this activation was
moderately stimulated in response to PMA compared to gas-
trin (1.7 þ 0.2-fold).
Pretreatment of the cells with 5 WM of a potent and speci¢c
PKC inhibitor, GF109203X, prevented the PMA-stimulated
p38K-MAPK activation (Fig. 2A,B). In contrast, p38K-
MAPK phosphorylation and activity induced by gastrin
were only partially inhibited by GF109203X (respectively
37.2 þ 9.6% and 79.1 þ 1.6%). These results indicate that max-
imal activation of p38K-MAPK by gastrin involves a PKC-
dependent mechanism but suggest the existence of an addi-
tional signaling pathway independent of PKCs. Our results
are in good correlation with a recent study that has shown
that GKq, which is known to be coupled to the CCKB recep-
tor, can stimulate p38-MAPK by a mechanism involving
PKCs [18].
Very little is known about the contribution of intracellular
calcium mobilization by GPCR to the activation of the p38-
MAPK pathway. To assess whether this early event particip-
ates to p38-MAPK activation, cells were treated for 45 min
with the calcium ionophore A23187. Both, p38K-MAPK
phosphorylation and activity (Fig. 2C,D) were increased in
response to 10 WM of A23187 (respectively 13.9 þ 5-fold and
5.3 þ 2.7-fold). In addition, gastrin-induced p38-MAPK acti-
vation was prevented by pretreatment of the cells with 1 WM
of thapsigargin, a selective inhibitor of the endoplasmic retic-
ulum ATPase which is responsible for maintaining intracellu-
lar calcium stores. These results demonstrate that intracellular
calcium plays a critical role in the activation of the p38-
MAPK pathway by the CCKB receptor.
3.3. Role of Src family tyrosine kinases in p38-MAPK
activation induced by gastrin
Expression of the v-Src oncoprotein has been shown to
strongly stimulate p38-MAPK in di¡erent cell types [19,20].
However little is known about the contribution of Src family
kinases to the signaling pathways linking GPCR to p38-
MAPK activation. We have previously reported that gastrin
can stimulate a Src kinase activity in CHO cells transfected
with the CCKB receptor [7]. In this study, we have analyzed
the role of intracellular calcium and certain PKC isoforms in
gastrin-induced Src kinase activity and determined whether
Src family tyrosine kinases are involved in the gastrin-induced
activation of p38-MAPK.
In Fig. 3A, activation of Src was measured in anti-Src im-
munoprecipitates using enolase as a substrate. A similar in-
crease in Src activity was observed after treatment with PMA
or gastrin (respectively 2.0 þ 0.2-fold and 2.6 þ 0.5-fold). Pre-
incubation of the cells with the PKC inhibitor, GF109203X,
completely blocked the maximal increase of Src kinase activity
obtained with both PMA and gastrin. Similarly, depletion of
the intracellular calcium pools with thapsigargin abolished
gastrin-induced Src kinase activity (Fig. 3B).
To determine the contribution of Src family kinases to the
activation of p38-MAPK by gastrin, we measured the phos-
phorylation and the activity of the kinase in CHO cells pre-
Fig. 2. Role of PKC and calcium in the activation of p38-MAPK
by gastrin. After 30 min pre-incubation with (+) or without (3)
5 WM of GF109203X (GF), or 1 WM of thapsigargin (TG), cells
were stimulated for 5 min with 10 nM of gastrin, for 20 min with
100 nM of PMA or for 45 min with 10 WM of A23187. Proteins
from cell lysates were immunoprecipitated with anti-phosphotyrosine
or anti-p38K-MAPK antibodies then subjected to immunoblotting
(A,C) or to p38K-MAPK assay (B,D) as described under Section 2.
Comparable amounts of proteins were detected in whole cell lysates
or immunoprecipitates of all the above experiments (data not
shown).
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treated with a speci¢c Src-like inhibitor PP2. In the presence
of 10 WM of PP2, that abolished the gastrin-stimulated Src
kinase activity (Fig. 3C), gastrin stimulation of p38K-MAPK
phosphorylation and activity were reduced by respectively
84.6 þ 0.1% and 86.0 þ 6.0% compared to control cells (Fig.
4A,B). The results indicate that p38-MAPK activation by
gastrin is mainly mediated by Src family kinases although a
Src-independent signaling pathway may also be involved.
3.4. E¡ect of wortmannin and LY294002, two PI 3-kinase
inhibitors, on gastrin-induced p38-MAPK activation
We have previously reported the activation of the p85/p110
PI 3-kinase by the CCKB receptor [17] and its role upstream
of the ERK pathway induced by gastrin [21]. We therefore
examined whether the PI 3-kinase pathway would be involved
in the activation of p38-MAPK by gastrin. For this purpose,
cells were treated with increasing an concentration of PI 3-
kinase inhibitors, wortmannin (1^1000 nM) and LY294002
(0.01^100 WM) prior to gastrin stimulation. In contrast to
what we previously observed for the ERK pathway, neither
phosphorylation of p38K-MAPK nor its activity induced by
gastrin was a¡ected by the PI 3-kinase inhibitors (Fig. 5).
3.5. Role of the p38-MAPK pathway in
gastrin-induced DNA synthesis
The importance of the p38-MAPK pathway in gastrin-
Fig. 3. Role of PKC and calcium in c-Src tyrosine kinases activa-
tion induced by gastrin. After 30 min pre-incubation with (+) or
without (3) 5 WM of GF109203X (GF), 1 WM of thapsigargin (TG)
or 10 WM of PP2, cells were stimulated for 1 min with 10 nM of
gastrin or for 20 min with 100 nM of PMA. Proteins from cell ly-
sates were prepared and subjected to Src kinase activity as described
under Section 2. Comparable amounts of proteins were detected in
whole cell lysates or immunoprecipitates of all the above experi-
ments (data not shown).
Fig. 4. Role of Src family tyrosine kinases in p38-MAPK activation
induced by gastrin. After 30 min pre-incubation with (+) or without
(3) 10 WM of PP2, cells were stimulated for 5 min with 10 nM of
gastrin. Proteins from cell lysates were immunoprecipitated with an
anti-phosphotyrosine antibody phosphotyrosine or anti-p38K-MAPK
antibodies then subjected to immunoblotting (A) or to p38K-MAPK
assay (B) as described under Section 2. Comparable amounts of
proteins were detected in whole cell lysates or immunoprecipitates
of all the above experiments (data not shown).
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stimulated CHO cells proliferation was investigated by using
the p38-MAPK inhibitor, SB203580.
Fig. 6A shows that pretreatment of the cells with 10 WM of
SB203580 completely blocked the activation of p38K-MAPK
by gastrin. At this concentration, the activation by gastrin of
the two other MAPKs, JNK and ERK was not signi¢cantly
inhibited (Fig. 6B,C). We therefore analyzed the e¡ect of
SB203580 on [3H]thymidine incorporation stimulated by gas-
trin (Fig. 6D). We observed a 86.4 þ 12.7% decrease of gas-
trin-induced DNA synthesis in pretreated cells compared to
control cells whereas SB203580 alone had no e¡ect on basal
[3H]thymidine incorporation. The p38-MAPK pathway has
previously been shown to be activated by GPCR. However,
the understanding is just beginning to emerge about the role
of p38-MAPK in the wide biological e¡ects of these receptors.
The p38-MAPK pathway has been involved in cell migration
mediated by the angiotensin receptor [22], cell scattering [23]
and inhibition of cell proliferation [24] mediated by the K1B-
adrenergic receptor and organization of the actin cytoskeleton
mediated by the CCKA receptor [25]. Here we show that the
p38-MAPK pathway can play a central role in growth-pro-
moting e¡ects mediated by the GPCR, CCKB.
In summary, our study reports the activation of p38K-
MAPK by the CCKB through a mechanism that involves
PKC, intracellular calcium mobilization and Src family ki-
nases. Our data also demonstrate a critical role for the p38-
MAPK pathway in transducing the proliferative activity of
gastrin.
Fig. 5. E¡ect of wortmannin and LY294002 on gastrin-induced p38-
MAPK activation. After 60 min pre-incubation with the indicated
concentrations of wortmannin (WM) or LY294002 (LY), cells were
incubated for 5 min with (+) or without (3) 10 nM of gastrin. Pro-
teins from cell lysates were immunoprecipitated with anti-phospho-
tyrosine or anti-p38K-MAPK antibodies then subjected to immuno-
blotting (A) or p38K-MAPK assay (B) as described under Section 2.
Comparable amounts of proteins were detected in whole cell lysates
or immunoprecipitates of all the above experiments (data not
shown). The autoradiograms are representative of three separate ex-
periments.
Fig. 6. Role of p38-MAPK pathway in gastrin-induced DNA syn-
thesis. A: Lysates from cells treated (+) or not (3) with 10 nM of
gastrin were prepared and subjected to p38K-MAPK assay in pres-
ence of the indicated concentrations of SB203580. B,C: After 30
min pre-incubation with (+) or without (3) 10 WM of SB203580
(SB), cells were incubated for 5 min with (+) or without (3) 10 nM
of gastrin. Cell lysates were prepared and subjected to ERK and
JNK assays as described under Section 2. D: After 30 min pre-incu-
bation with (+) or without (3) 10 WM of SB203580 (SB), cells were
stimulated for 24 h with 100 nM of gastrin. DNA synthesis was
measured by [3H]thymidine incorporation under serum-free condi-
tions as described under Section 2. Maximal [3H]thymidine incorpo-
ration induced by gastrin averaged 140 þ 6%.
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